GR3018343T3 - Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment. - Google Patents

Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment.

Info

Publication number
GR3018343T3
GR3018343T3 GR950403462T GR950403462T GR3018343T3 GR 3018343 T3 GR3018343 T3 GR 3018343T3 GR 950403462 T GR950403462 T GR 950403462T GR 950403462 T GR950403462 T GR 950403462T GR 3018343 T3 GR3018343 T3 GR 3018343T3
Authority
GR
Greece
Prior art keywords
hetero
nitro
aromatic
cancer treatment
substituted aromatic
Prior art date
Application number
GR950403462T
Other languages
English (en)
Inventor
Gerald Edward Adams
Edward Martin Fielden
Terence Charles Jenkins
Ian James Stratford
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878728418A external-priority patent/GB8728418D0/en
Application filed by British Tech Group filed Critical British Tech Group
Publication of GR3018343T3 publication Critical patent/GR3018343T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/95Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR950403462T 1987-12-04 1995-12-08 Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment. GR3018343T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878728418A GB8728418D0 (en) 1987-12-04 1987-12-04 Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
GB888818348A GB8818348D0 (en) 1987-12-04 1988-08-02 Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer

Publications (1)

Publication Number Publication Date
GR3018343T3 true GR3018343T3 (en) 1996-03-31

Family

ID=26293154

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950403462T GR3018343T3 (en) 1987-12-04 1995-12-08 Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment.

Country Status (10)

Country Link
US (1) US5098921A (el)
EP (1) EP0319329B1 (el)
JP (1) JPH01250360A (el)
AT (1) ATE129703T1 (el)
AU (1) AU625314B2 (el)
CA (1) CA1332738C (el)
DE (1) DE3854645T2 (el)
ES (1) ES2080726T3 (el)
GB (1) GB2213150B (el)
GR (1) GR3018343T3 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728418D0 (en) * 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
US5073639A (en) * 1988-11-25 1991-12-17 Warner-Lambert Company Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents
US5036096A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives
GB9113487D0 (en) * 1991-06-21 1991-08-07 Amersham Int Plc Agents for hypoxic cells
DE4134224C2 (de) * 1991-10-16 2001-06-07 Apogepha Arzneimittel Gmbh Neue 1-Heterocyclylmethyl-3-nitro-1,2,4-triazole
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
GB9404400D0 (en) * 1994-03-07 1994-04-20 Wood Pauline J Potentiation of bioreductive agents
JP2000247881A (ja) * 1999-02-26 2000-09-12 Tsutomu Kagitani 免疫増強剤
CN1270062A (zh) * 1999-04-08 2000-10-18 广州山河药业股份有限公司 一种放射、化学治疗增效剂—甘氨双唑金属盐及其制法和用途
US20060099712A1 (en) * 2004-11-08 2006-05-11 Eastman Kodak Company Correlation of anti-cancer activity of dyes with redox potentials
US7842278B2 (en) * 2006-10-27 2010-11-30 Natural Pharmacia International, Inc. Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1257238A (el) * 1968-10-31 1971-12-15
GB1425293A (en) * 1974-01-17 1976-02-18 Hoffmann La Roche Carbamate derivatives of 2-nitro-1-imidazol-alkanols-, emthods for their preparation and compositions containing them
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
DE2948884A1 (de) * 1979-12-05 1981-06-11 Basf Ag, 6700 Ludwigshafen 2-hydroxypropylimidazole, verfahren zu ihrer herstellung und verwendung als oelloesliche korrosionsinhibitoren
ATE23041T1 (de) * 1982-05-27 1986-11-15 Nat Res Dev Verbindungen anwendbar in strahlentherapie und chemotherapie.
CA1227211A (en) * 1982-05-27 1987-09-22 National Research Development Corporation Nitro imidazolyl aziridino propanols
GB2131020B (en) * 1982-11-25 1986-10-01 Gerald Edward Adams Improvements relating to compounds useful in radiotherapy or chemotherapy

Also Published As

Publication number Publication date
AU2651088A (en) 1989-06-08
DE3854645T2 (de) 1996-05-02
CA1332738C (en) 1994-10-25
ATE129703T1 (de) 1995-11-15
EP0319329A2 (en) 1989-06-07
JPH01250360A (ja) 1989-10-05
ES2080726T3 (es) 1996-02-16
EP0319329A3 (en) 1990-03-07
EP0319329B1 (en) 1995-11-02
GB2213150B (en) 1991-10-02
GB8828196D0 (en) 1989-01-05
DE3854645D1 (de) 1995-12-07
AU625314B2 (en) 1992-07-09
GB2213150A (en) 1989-08-09
US5098921A (en) 1992-03-24

Similar Documents

Publication Publication Date Title
GB2213150B (en) Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment
BG60307B2 (en) Method for obtaining of substituted two-ring compounds
HUT45976A (en) Process for production of new substituated imidasole derivatives and medical compositions containing such compounds
GR3015850T3 (en) Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process.
WO1998050346A3 (en) Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
EP0430045A3 (en) Ascorbic acid tocopheryl phosphate diesters for inhibition of maillard's reaction
DE68906309D1 (de) Methode zur behandlung von kachexie und bestimmte dafuer anzuwendende verbindungen.
MY131193A (en) 7-(2-aminoethyl)-benzothiazolones
GR74571B (el)
EP0219782A3 (en) Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease
GR3005461T3 (el)
PT84157A (en) Process for preparing heptanoyl-glu-asp-ala-amino acid immunostimmulants
ES8604960A1 (es) Procedimiento para preparar derivados de 1,6-naftiridina
EP0299076A4 (en) 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
GB8706662D0 (en) Anti-arrhythmia agents
HUT44515A (en) Process for producing isoquinolinol compounds of heart activity increasing, phosphodiesterase iii inhibiting and/or renal vasodilating activity and pharmaceutical composition containing them
ES8507476A1 (es) Un procedimiento para la preparacion de nuevos benzonitrilos
GR930300124T1 (en) Bile acid sulfurated derivatives
US3952036A (en) 1,1-(Thiadialkylidene) ferrocene S-oxides
ES8305350A1 (es) "un procedimiento para preparar derivados de dialcohilpirazol".
ES2000614A6 (es) Procedimiento de obtencion de nuevos complejos de platino (ii) derivados del 2,3-dimercapto-2-butene-dinitrilato (2-)-s,s'"
CA1254219A (en) Nitro imidazolyl aziridino propanols
IL86136A0 (en) Thiadiazole guanidines,process for preparation thereof and pharmaceutical compositions containing the same
ES8708226A1 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina
ES8707249A1 (es) Un procedimiento para preparar derivados de fosfina y oro